1. Home
  2. CHN vs NMRA Comparison

CHN vs NMRA Comparison

Compare CHN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHN
  • NMRA
  • Stock Information
  • Founded
  • CHN 1992
  • NMRA 2019
  • Country
  • CHN United States
  • NMRA United States
  • Employees
  • CHN N/A
  • NMRA N/A
  • Industry
  • CHN Investment Managers
  • NMRA
  • Sector
  • CHN Finance
  • NMRA
  • Exchange
  • CHN Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • CHN 128.4M
  • NMRA 121.0M
  • IPO Year
  • CHN N/A
  • NMRA 2023
  • Fundamental
  • Price
  • CHN $13.07
  • NMRA $0.77
  • Analyst Decision
  • CHN
  • NMRA Buy
  • Analyst Count
  • CHN 0
  • NMRA 8
  • Target Price
  • CHN N/A
  • NMRA $9.29
  • AVG Volume (30 Days)
  • CHN 31.8K
  • NMRA 820.4K
  • Earning Date
  • CHN 01-01-0001
  • NMRA 08-05-2025
  • Dividend Yield
  • CHN 0.19%
  • NMRA N/A
  • EPS Growth
  • CHN N/A
  • NMRA N/A
  • EPS
  • CHN N/A
  • NMRA N/A
  • Revenue
  • CHN N/A
  • NMRA N/A
  • Revenue This Year
  • CHN N/A
  • NMRA N/A
  • Revenue Next Year
  • CHN N/A
  • NMRA N/A
  • P/E Ratio
  • CHN N/A
  • NMRA N/A
  • Revenue Growth
  • CHN N/A
  • NMRA N/A
  • 52 Week Low
  • CHN $9.00
  • NMRA $0.61
  • 52 Week High
  • CHN $12.98
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • CHN 58.19
  • NMRA 45.74
  • Support Level
  • CHN $13.13
  • NMRA $0.81
  • Resistance Level
  • CHN $13.33
  • NMRA $1.34
  • Average True Range (ATR)
  • CHN 0.17
  • NMRA 0.10
  • MACD
  • CHN 0.01
  • NMRA -0.01
  • Stochastic Oscillator
  • CHN 75.70
  • NMRA 12.55

About CHN China Fund Inc. (The)

CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: